Changchun BCHT Biotechnology Future Growth
Future criteria checks 5/6
Changchun BCHT Biotechnology is forecast to grow earnings and revenue by 27.1% and 22.6% per annum respectively. EPS is expected to grow by 26.3% per annum. Return on equity is forecast to be 17.4% in 3 years.
Key information
27.1%
Earnings growth rate
26.3%
EPS growth rate
| Biotechs earnings growth | 33.0% |
| Revenue growth rate | 22.6% |
| Future return on equity | 17.4% |
| Analyst coverage | Good |
| Last updated | 09 Apr 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,656 | 1,176 | N/A | 988 | 5 |
| 12/31/2025 | 3,105 | 958 | N/A | 767 | 6 |
| 12/31/2024 | 2,487 | 722 | N/A | 437 | 6 |
| 3/31/2024 | 1,916 | 543 | -249 | 252 | N/A |
| 12/31/2023 | 1,825 | 501 | -215 | 255 | N/A |
| 9/30/2023 | 1,449 | 301 | -260 | 254 | N/A |
| 6/30/2023 | 1,190 | 219 | -308 | 141 | N/A |
| 3/31/2023 | 1,113 | 183 | -185 | 117 | N/A |
| 12/31/2022 | 1,071 | 182 | -251 | 40 | N/A |
| 9/30/2022 | 1,123 | 222 | -126 | 74 | N/A |
| 6/30/2022 | 1,061 | 179 | -301 | 101 | N/A |
| 3/31/2022 | 1,093 | 205 | -414 | 138 | N/A |
| 12/31/2021 | 1,202 | 244 | -493 | 140 | N/A |
| 9/30/2021 | 1,304 | 309 | -486 | 141 | N/A |
| 6/30/2021 | 1,424 | 377 | -280 | 230 | N/A |
| 3/31/2021 | 1,489 | 424 | -189 | 191 | N/A |
| 12/31/2020 | 1,441 | 418 | -127 | 209 | N/A |
| 12/31/2019 | 976 | 221 | 104 | 233 | N/A |
| 12/31/2018 | 1,019 | 128 | 89 | 270 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688276's forecast earnings growth (27.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 688276's earnings (27.1% per year) are forecast to grow faster than the CN market (23.9% per year).
High Growth Earnings: 688276's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688276's revenue (22.6% per year) is forecast to grow faster than the CN market (14.3% per year).
High Growth Revenue: 688276's revenue (22.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688276's Return on Equity is forecast to be low in 3 years time (17.4%).